Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Bone Marrow Transplantation|July 1, 1989
Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG)G Santini, P Coser, T Chisesi, et al.European Journal of Cancer & Clinical Oncology|May 1, 1985
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's diseaseA M Carella, G Santini, A Santoro, et al.Haematologica|November 1, 1991
Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG)G Santini, A Contu, A Porcellini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)G Santini, P Coser, T Chisesi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study GroupM R Sertoli, G Santini, T Chisesi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group reportA M Carella, A M Congiu, E Gaozza, et al.Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.Leukemia & Lymphoma|May 9, 2001
Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patientsT Chisesi, P Polistena, A Contu, et al.Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.Blood|March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)A Bacigalupo, B Bruno, P Saracco, et al.Pageof 4